|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 963.61 USD | +0.72% |
|
+4.19% | +11.74% |
| 16/01 | Novo's Wegovy pill makes encouraging start in weight-loss race vs Lilly | RE |
| 16/01 | Costco Wholesale Keeps Quarterly Dividend at $1.30 a Share, Payable Feb. 13 to Holders of Record Jan. 30 | MT |
| Fiscal Period: August | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.86 | 7.89 | 7.98 | 8.36 | 8.83 | |||||
Return on Total Capital | 15.23 | 15.96 | 15.83 | 16.78 | 17.86 | |||||
Return On Equity % | 27.62 | 30.55 | 27.53 | 30.27 | 30.69 | |||||
Return on Common Equity | 27.93 | 30.59 | 27.54 | 30.27 | 30.69 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 12.88 | 12.15 | 12.42 | 12.61 | 12.84 | |||||
SG&A Margin | 9.16 | 8.71 | 8.91 | 8.96 | 9.07 | |||||
EBITDA Margin % | 4.6 | 4.27 | 4.37 | 4.53 | 4.65 | |||||
EBITA Margin % | 3.69 | 3.43 | 3.51 | 3.65 | 3.77 | |||||
EBIT Margin % | 3.69 | 3.43 | 3.51 | 3.65 | 3.77 | |||||
Income From Continuing Operations Margin % | 2.59 | 2.61 | 2.6 | 2.9 | 2.94 | |||||
Net Income Margin % | 2.56 | 2.57 | 2.6 | 2.9 | 2.94 | |||||
Net Avail. For Common Margin % | 2.56 | 2.57 | 2.6 | 2.9 | 2.94 | |||||
Normalized Net Income Margin | 2.26 | 2.13 | 2.29 | 2.39 | 2.46 | |||||
Levered Free Cash Flow Margin | 2.35 | 1 | 2.25 | 1.76 | 2.14 | |||||
Unlevered Free Cash Flow Margin | 2.41 | 1.05 | 2.29 | 1.8 | 2.18 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 3.41 | 3.68 | 3.64 | 3.67 | 3.75 | |||||
Fixed Assets Turnover | 7.45 | 8.04 | 8.11 | 7.98 | 7.95 | |||||
Receivables Turnover (Average Receivables) | 116.87 | 112.24 | 107.07 | 101.66 | 92.92 | |||||
Inventory Turnover (Average Inventory) | 12.9 | 12.41 | 12.28 | 12.6 | 13.05 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1 | 1.02 | 1.07 | 0.97 | 1.03 | |||||
Quick Ratio | 0.47 | 0.42 | 0.52 | 0.39 | 0.5 | |||||
Operating Cash Flow to Current Liabilities | 0.3 | 0.23 | 0.33 | 0.32 | 0.36 | |||||
Days Sales Outstanding (Average Receivables) | 3.11 | 3.24 | 3.47 | 3.58 | 3.92 | |||||
Days Outstanding Inventory (Average Inventory) | 28.21 | 29.32 | 30.21 | 28.89 | 27.89 | |||||
Average Days Payable Outstanding | 32.1 | 30.58 | 31.07 | 29.94 | 29.81 | |||||
Cash Conversion Cycle (Average Days) | -0.77 | 1.98 | 2.61 | 2.53 | 2 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 63.1 | 52.82 | 42.05 | 42.12 | 34.07 | |||||
Total Debt / Total Capital | 38.69 | 34.56 | 29.6 | 29.64 | 25.41 | |||||
LT Debt/Equity | 57.05 | 50.12 | 36.34 | 40.3 | 32.83 | |||||
Long-Term Debt / Total Capital | 34.98 | 32.8 | 25.58 | 28.36 | 24.49 | |||||
Total Liabilities / Total Assets | 69.5 | 67.82 | 63.68 | 66.17 | 62.17 | |||||
EBIT / Interest Expense | 42.24 | 49.32 | 53.16 | 54.94 | 67.42 | |||||
EBITDA / Interest Expense | 55.27 | 64.22 | 69.07 | 70.82 | 86.12 | |||||
(EBITDA - Capex) / Interest Expense | 34.29 | 39.59 | 42.05 | 42.95 | 50.42 | |||||
Total Debt / EBITDA | 1.21 | 1.07 | 0.95 | 0.83 | 0.75 | |||||
Net Debt / EBITDA | -0.08 | -0.01 | -0.43 | -0.1 | -0.4 | |||||
Total Debt / (EBITDA - Capex) | 1.95 | 1.74 | 1.57 | 1.37 | 1.28 | |||||
Net Debt / (EBITDA - Capex) | -0.13 | -0.02 | -0.7 | -0.16 | -0.69 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 17.49 | 15.83 | 6.76 | 5.02 | 8.17 | |||||
Gross Profit, 1 Yr. Growth % | 15.69 | 9.22 | 9.15 | 6.65 | 10.14 | |||||
EBITDA, 1 Yr. Growth % | 27.18 | 7.65 | 7.86 | 8.88 | 11.17 | |||||
EBITA, 1 Yr. Growth % | 32.9 | 7.89 | 7.51 | 9.17 | 11.83 | |||||
EBIT, 1 Yr. Growth % | 32.9 | 7.89 | 7.51 | 9.17 | 11.83 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 25.13 | 16.46 | 6.37 | 17.09 | 9.94 | |||||
Net Income, 1 Yr. Growth % | 25.11 | 16.72 | 7.67 | 17.09 | 9.94 | |||||
Normalized Net Income, 1 Yr. Growth % | 33.28 | 9.13 | 13.18 | 9.71 | 11.07 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 24.94 | 16.59 | 7.76 | 16.95 | 9.96 | |||||
Accounts Receivable, 1 Yr. Growth % | 16.32 | 24.29 | 1.96 | 19.08 | 17.71 | |||||
Inventory, 1 Yr. Growth % | 16.12 | 25.97 | -7.01 | 11.99 | -2.85 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 8.71 | 6.06 | 5.79 | 7.68 | 9.19 | |||||
Total Assets, 1 Yr. Growth % | 6.68 | 8.26 | 7.52 | 1.21 | 10.41 | |||||
Tangible Book Value, 1 Yr. Growth % | -4.21 | 18.6 | 22.47 | -5.97 | 19.56 | |||||
Common Equity, 1 Yr. Growth % | -3.94 | 17.52 | 21.39 | -5.73 | 23.46 | |||||
Cash From Operations, 1 Yr. Growth % | 1.09 | -17.48 | 49.73 | 2.45 | 17.6 | |||||
Capital Expenditures, 1 Yr. Growth % | 27.69 | 8.44 | 11.1 | 8.95 | 16.73 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -7.34 | -50.54 | 131.78 | -18.14 | 32.05 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -7.06 | -49.57 | 126.53 | -17.71 | 31.1 | |||||
Dividend Per Share, 1 Yr. Growth % | 10.37 | 13.42 | 13.61 | 13.54 | 12.84 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 13.27 | 16.66 | 11.2 | 5.89 | 6.58 | |||||
Gross Profit, 2 Yr. CAGR % | 12.87 | 12.41 | 9.18 | 7.89 | 8.38 | |||||
EBITDA, 2 Yr. CAGR % | 20.23 | 17.01 | 11.1 | 8.37 | 10.02 | |||||
EBITA, 2 Yr. CAGR % | 23.48 | 19.74 | 11.9 | 8.34 | 10.49 | |||||
EBIT, 2 Yr. CAGR % | 23.48 | 19.74 | 11.9 | 8.34 | 10.49 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 17.1 | 20.72 | 11.3 | 11.6 | 13.45 | |||||
Net Income, 2 Yr. CAGR % | 16.98 | 20.84 | 12.1 | 12.28 | 13.45 | |||||
Normalized Net Income, 2 Yr. CAGR % | 22.82 | 21.02 | 15.55 | 11.43 | 10.39 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 16.81 | 20.7 | 12.09 | 12.26 | 13.4 | |||||
Accounts Receivable, 2 Yr. CAGR % | 8.38 | 20.24 | 12.58 | 10.19 | 18.4 | |||||
Inventory, 2 Yr. CAGR % | 11.69 | 20.94 | 8.23 | 2.05 | 4.31 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 14.49 | 7.38 | 5.92 | 6.73 | 8.43 | |||||
Total Assets, 2 Yr. CAGR % | 14.26 | 7.47 | 7.89 | 4.32 | 5.71 | |||||
Tangible Book Value, 2 Yr. CAGR % | 4.44 | 6.59 | 20.52 | 7.31 | 8.27 | |||||
Common Equity, 2 Yr. CAGR % | 7.34 | 6.25 | 19.44 | 6.98 | 7.88 | |||||
Cash From Operations, 2 Yr. CAGR % | 18.72 | -8.66 | 11.16 | 23.85 | 9.76 | |||||
Capital Expenditures, 2 Yr. CAGR % | 9.4 | 17.67 | 9.77 | 10.02 | 12.77 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 33.28 | -32.3 | 12.11 | 37.74 | 3.97 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 32.45 | -31.54 | 11.77 | 36.53 | 3.86 | |||||
Dividend Per Share, 2 Yr. CAGR % | 10.51 | 11.89 | 13.52 | 13.58 | 13.19 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 11.44 | 14.12 | 13.26 | 9.1 | 6.64 | |||||
Gross Profit, 3 Yr. CAGR % | 11.07 | 11.64 | 11.31 | 8.33 | 8.63 | |||||
EBITDA, 3 Yr. CAGR % | 15.02 | 15.88 | 14.33 | 10.36 | 9.3 | |||||
EBITA, 3 Yr. CAGR % | 17.26 | 18.05 | 16.1 | 10.98 | 9.49 | |||||
EBIT, 3 Yr. CAGR % | 17.26 | 18.05 | 16.1 | 10.98 | 9.49 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 16.9 | 16.89 | 15.73 | 13.2 | 11.04 | |||||
Net Income, 3 Yr. CAGR % | 16.9 | 16.89 | 16.28 | 13.74 | 11.49 | |||||
Normalized Net Income, 3 Yr. CAGR % | 17.45 | 18.08 | 18.94 | 13.57 | 11.31 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 16.71 | 16.74 | 16.22 | 13.69 | 11.49 | |||||
Accounts Receivable, 3 Yr. CAGR % | 2.61 | 13.44 | 13.81 | 14.7 | 12.64 | |||||
Inventory, 3 Yr. CAGR % | 8.79 | 16.26 | 10.8 | 9.47 | 0.39 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 11.64 | 11.61 | 6.85 | 6.51 | 7.55 | |||||
Total Assets, 3 Yr. CAGR % | 13.23 | 12.22 | 7.49 | 5.62 | 6.31 | |||||
Tangible Book Value, 3 Yr. CAGR % | 8.98 | 8.96 | 11.64 | 10.95 | 12.81 | |||||
Common Equity, 3 Yr. CAGR % | 11.13 | 10.64 | 11.08 | 10.38 | 12.21 | |||||
Cash From Operations, 3 Yr. CAGR % | 15.77 | 5.16 | 7.7 | 8.17 | 21.73 | |||||
Capital Expenditures, 3 Yr. CAGR % | 6.52 | 9.08 | 15.44 | 9.49 | 12.21 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 20.32 | -4.22 | 3.12 | 0.95 | 35.82 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 19.76 | -4 | 3.06 | 0.92 | 34.69 | |||||
Dividend Per Share, 3 Yr. CAGR % | 11.67 | 11.47 | 12.46 | 13.52 | 13.33 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 10.54 | 11.96 | 11.34 | 10.75 | 10.54 | |||||
Gross Profit, 5 Yr. CAGR % | 9.8 | 9.97 | 10.31 | 10.12 | 10.13 | |||||
EBITDA, 5 Yr. CAGR % | 12.82 | 12.08 | 12.33 | 13.09 | 12.59 | |||||
EBITA, 5 Yr. CAGR % | 14.49 | 13.65 | 13.68 | 14.41 | 13.82 | |||||
EBIT, 5 Yr. CAGR % | 14.49 | 13.65 | 13.68 | 14.41 | 13.82 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 16.41 | 16.86 | 14.63 | 14.74 | 14.82 | |||||
Net Income, 5 Yr. CAGR % | 16.33 | 16.88 | 14.96 | 15.02 | 15.14 | |||||
Normalized Net Income, 5 Yr. CAGR % | 14.63 | 14.17 | 15.23 | 15.72 | 15.44 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 16.16 | 16.66 | 14.84 | 14.93 | 15.09 | |||||
Accounts Receivable, 5 Yr. CAGR % | 7.57 | 9.37 | 6.48 | 12.13 | 15.62 | |||||
Inventory, 5 Yr. CAGR % | 9.65 | 12.73 | 8.57 | 10.35 | 8.15 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 9.95 | 9.84 | 9.32 | 9.63 | 7.48 | |||||
Total Assets, 5 Yr. CAGR % | 12.31 | 12.04 | 11.06 | 8.99 | 6.77 | |||||
Tangible Book Value, 5 Yr. CAGR % | 6.52 | 12.76 | 13.46 | 8.3 | 10.28 | |||||
Common Equity, 5 Yr. CAGR % | 7.78 | 13.88 | 14.38 | 9.16 | 9.79 | |||||
Cash From Operations, 5 Yr. CAGR % | 22.17 | 1.91 | 13.9 | 12.27 | 8.52 | |||||
Capital Expenditures, 5 Yr. CAGR % | 6.26 | 9.23 | 7.8 | 9.46 | 14.37 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 65.91 | -9.48 | 15.57 | 11.47 | 3.46 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 60 | -9.11 | 15.13 | 11.2 | 3.38 | |||||
Dividend Per Share, 5 Yr. CAGR % | 11.88 | 12.21 | 12.4 | 12.31 | 12.75 |
- Stock Market
- Equities
- COST Stock
- Financials Costco Wholesale Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















